Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1992 Sep;67(9):1095–1102. doi: 10.1136/adc.67.9.1095

Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

K H Hsieh 1, M F Shaio 1, T N Liao 1
PMCID: PMC1793621  PMID: 1329673

Abstract

An open clinical trial of thymopentin was conducted on 16 children with severe atopic dermatitis. The patients were treated with injections three times a week of 50 mg thymopentin for six weeks. They were then divided randomly into two groups: group A continued thymopentin for an additional six weeks, and group B were treated with normal saline. Clinical parameters and immunological function were evaluated serially. The total severity score started to decline from baseline significantly three weeks after treatment, and continued throughout the study period in group A but began to flare up in group B two weeks after stopping thymopentin. All the eight patients in group A completed the trial but three out of eight in group B dropped out because of flaring up of skin lesion. In vitro production of interleukin-4 tended to decrease and that of interferon gamma tended to increase, but total serum IgE, in vitro IgE synthesis, and abnormally low CD8+ CD11b+ suppressor T cells remained unchanged. Histamine releasing factor (HRF), plasma histamine, and respiratory burst activities of polymorphonuclear leucocytes were appreciably decreased after thymopentin treatment. It is concluded that the clinical efficacy of short term thymopentin treatment very possibly results from the decreased production of HRF and decreased release of polymorphonuclear leucocyte derived inflammatory mediators and may have no relation with antigen-IgE immune reaction.

Full text

PDF
1095

Images in this article

1098Figure 2
on p.1098

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belli D. C., Levy E., Darling P., Leroy C., Lepage G., Giguère R., Roy C. C. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Pediatrics. 1987 Oct;80(4):517–523. [PubMed] [Google Scholar]
  2. Chiarelli F., Canfora G., Verrotti A., Amerio P., Morgese G. Humoral and cellular immunity in children with active and quiescent atopic dermatitis. Br J Dermatol. 1987 May;116(5):651–660. doi: 10.1111/j.1365-2133.1987.tb05898.x. [DOI] [PubMed] [Google Scholar]
  3. Colombo C., Arlati S., Curcio L., Maiavacca R., Garatti M., Ronchi M., Corbetta C., Giunta A. Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis. Scand J Gastroenterol Suppl. 1988;143:151–156. doi: 10.3109/00365528809090237. [DOI] [PubMed] [Google Scholar]
  4. Darling P. B., Lepage G., Leroy C., Masson P., Roy C. C. Effect of taurine supplements on fat absorption in cystic fibrosis. Pediatr Res. 1985 Jun;19(6):578–582. doi: 10.1203/00006450-198506000-00015. [DOI] [PubMed] [Google Scholar]
  5. De Curtis M., Senterre J., Rigo J. Estimated and measured energy content of infant formulas. J Pediatr Gastroenterol Nutr. 1986 Sep-Oct;5(5):746–749. doi: 10.1097/00005176-198609000-00014. [DOI] [PubMed] [Google Scholar]
  6. Del Prete G., Maggi E., Parronchi P., Chrétien I., Tiri A., Macchia D., Ricci M., Banchereau J., De Vries J., Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol. 1988 Jun 15;140(12):4193–4198. [PubMed] [Google Scholar]
  7. Diezel W., Waschke S. R., Forner K. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide. Biomed Biochim Acta. 1984;43(6):K9–12. [PubMed] [Google Scholar]
  8. Durie P. R., Bell L., Linton W., Corey M. L., Forstner G. G. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut. 1980 Sep;21(9):778–786. doi: 10.1136/gut.21.9.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fitzpatrick W. J., Zentler-Munro P. L., Northfield T. C. Ileal resection: effect of cimetidine and taurine on intrajejunal bile acid precipitation and lipid solubilisation. Gut. 1986 Jan;27(1):66–72. doi: 10.1136/gut.27.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fondacaro J. D., Heubi J. E., Kellogg F. W. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr Res. 1982 Jun;16(6):494–498. doi: 10.1203/00006450-198206000-00019. [DOI] [PubMed] [Google Scholar]
  11. Galeano N. F., Darling P., Lepage G., Leroy C., Collet S., Giguère R., Roy C. C. Taurine supplementation of a premature formula improves fat absorption in preterm infants. Pediatr Res. 1987 Jul;22(1):67–71. doi: 10.1203/00006450-198707000-00016. [DOI] [PubMed] [Google Scholar]
  12. Goldstein G., Audhya T. K. Thymopoietin to thymopentin: experimental studies. Surv Immunol Res. 1985;4 (Suppl 1):1–10. doi: 10.1007/BF02919050. [DOI] [PubMed] [Google Scholar]
  13. Goldstein G., Scheid M. P., Boyse E. A., Schlesinger D. H., Van Wauwe J. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science. 1979 Jun 22;204(4399):1309–1310. doi: 10.1126/science.451537. [DOI] [PubMed] [Google Scholar]
  14. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods. 1987 Mar 12;97(2):209–213. doi: 10.1016/0022-1759(87)90461-3. [DOI] [PubMed] [Google Scholar]
  15. Hsieh K. H. Altered interleukin-2 (IL-2) production and responsiveness after hyposensitization to house dust. J Allergy Clin Immunol. 1985 Aug;76(2 Pt 1):188–194. doi: 10.1016/0091-6749(85)90700-6. [DOI] [PubMed] [Google Scholar]
  16. Hsieh K. H. Decreased production of CD8 (T8) antigen after immunotherapy. J Clin Immunol. 1989 Mar;9(2):111–118. doi: 10.1007/BF00916938. [DOI] [PubMed] [Google Scholar]
  17. Hsieh K. H., Shen J. J. Prevalence of childhood asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma. 1988;25(2):73–82. doi: 10.3109/02770908809071357. [DOI] [PubMed] [Google Scholar]
  18. Jabara H. H., Ackerman S. J., Vercelli D., Yokota T., Arai K., Abrams J., Dvorak A. M., Lavigne M. C., Banchereau J., De Vries J. Induction of interleukin-4-dependent IgE synthesis and interleukin-5-dependent eosinophil differentiation by supernatants of a human helper T-cell clone. J Clin Immunol. 1988 Nov;8(6):437–446. doi: 10.1007/BF00916948. [DOI] [PubMed] [Google Scholar]
  19. Johnson E. E., Irons J. S., Patterson R., Roberts M. Serum IgE concentration in atopic dermatitis. Relationship to severity of disease and presence of atopic respiratory disease. J Allergy Clin Immunol. 1974 Aug;54(2):94–99. doi: 10.1016/0091-6749(74)90037-2. [DOI] [PubMed] [Google Scholar]
  20. Järvenpä A. L. Feeding the low-birth-weight infant. IV. Fat absorption as a function of diet and duodenal bile acids. Pediatrics. 1983 Nov;72(5):684–689. [PubMed] [Google Scholar]
  21. Kang K., Cooper K. D., Hanifin J. M. Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis. J Am Acad Dermatol. 1983 Mar;8(3):372–377. doi: 10.1016/s0190-9622(83)70042-3. [DOI] [PubMed] [Google Scholar]
  22. Kjellman N. I. Atopic disease in seven-year-old children. Incidence in relation to family history. Acta Paediatr Scand. 1977 Jul;66(4):465–471. doi: 10.1111/j.1651-2227.1977.tb07928.x. [DOI] [PubMed] [Google Scholar]
  23. Leung D. Y., Geha R. S. Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy. 1986 Feb;4(1):67–86. doi: 10.1007/BF02991188. [DOI] [PubMed] [Google Scholar]
  24. Leung D. Y., Hirsch R. L., Schneider L., Moody C., Takaoka R., Li S. H., Meyerson L. A., Mariam S. G., Goldstein G., Hanifin J. M. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol. 1990 May;85(5):927–933. doi: 10.1016/0091-6749(90)90079-j. [DOI] [PubMed] [Google Scholar]
  25. Leung D. Y., Parkman R., Feller J., Wood N., Geha R. S. Cell-mediated cytotoxicity against skin fibroblasts in atopic dermatitis. J Immunol. 1982 Apr;128(4):1736–1741. [PubMed] [Google Scholar]
  26. Leung D. Y., Saryan J. A., Frankel R., Lareau M., Geha R. S. Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis. J Clin Invest. 1983 Oct;72(4):1482–1486. doi: 10.1172/JCI111104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leung D. Y., Wood N., Dubey D., Rhodes A. R., Geha R. S. Cellular basis of defective cell-mediated lympholysis in atopic dermatitis. J Immunol. 1983 Apr;130(4):1678–1682. [PubMed] [Google Scholar]
  28. Li J. T., Yunginger J. W., Reed C. E., Jaffe H. S., Nelson D. R., Gleich G. J. Lack of suppression of IgE production by recombinant interferon gamma: a controlled trial in patients with allergic rhinitis. J Allergy Clin Immunol. 1990 May;85(5):934–940. doi: 10.1016/0091-6749(90)90080-n. [DOI] [PubMed] [Google Scholar]
  29. Liao T. N., Hsieh K. H. Altered production of histamine-releasing factor (HRF) activity and responsiveness to HRF after immunotherapy in children with asthma. J Allergy Clin Immunol. 1990 Dec;86(6 Pt 1):894–901. doi: 10.1016/s0091-6749(05)80152-6. [DOI] [PubMed] [Google Scholar]
  30. Meroni P. L., Barcellini W., Frasca D., Sguotti C., Borghi M. O., De Bartolo G., Doria G., Zanussi C. In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Clin Immunol Immunopathol. 1987 Feb;42(2):151–159. doi: 10.1016/0090-1229(87)90002-x. [DOI] [PubMed] [Google Scholar]
  31. Murphy J. L., Wootton S. A., Bond S. A., Jackson A. A. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child. 1991 Apr;66(4):495–500. doi: 10.1136/adc.66.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nokes D. J., Anderson R. M. Vaccine safety versus vaccine efficacy in mass immunisation programmes. Lancet. 1991 Nov 23;338(8778):1309–1312. doi: 10.1016/0140-6736(91)92601-w. [DOI] [PubMed] [Google Scholar]
  33. Okamoto E., Rassin D. K., Zucker C. L., Salen G. S., Heird W. C. Role of taurine in feeding the low-birth-weight infant. J Pediatr. 1984 Jun;104(6):936–940. doi: 10.1016/s0022-3476(84)80503-x. [DOI] [PubMed] [Google Scholar]
  34. Pick E., Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. 1980;38(1-2):161–170. doi: 10.1016/0022-1759(80)90340-3. [DOI] [PubMed] [Google Scholar]
  35. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981;46(2):211–226. doi: 10.1016/0022-1759(81)90138-1. [DOI] [PubMed] [Google Scholar]
  36. Pène J., Rousset F., Brière F., Chrétien I., Bonnefoy J. Y., Spits H., Yokota T., Arai N., Arai K., Banchereau J. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6880–6884. doi: 10.1073/pnas.85.18.6880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Reinhold U., Pawelec G., Wehrmann W., Herold M., Wernet P., Kreysel H. W. Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. Int Arch Allergy Appl Immunol. 1988;87(2):120–126. doi: 10.1159/000234661. [DOI] [PubMed] [Google Scholar]
  38. Rosen H., Klebanoff S. J. Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest. 1976 Jul;58(1):50–60. doi: 10.1172/JCI108458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sampson H. A., Broadbent K. R., Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med. 1989 Jul 27;321(4):228–232. doi: 10.1056/NEJM198907273210405. [DOI] [PubMed] [Google Scholar]
  40. Saryan J. A., Leung D. Y., Geha R. S. Induction of human IgE synthesis by a factor derived from T cells of patients with hyper-IgE states. J Immunol. 1983 Jan;130(1):242–247. [PubMed] [Google Scholar]
  41. Saurat J. H. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol Suppl (Stockh) 1985;114:125–128. [PubMed] [Google Scholar]
  42. Scheid M. P., Goldstein G., Boyse E. A. The generation and regulation of lymphocyte populations: evidence from differentiative induction systems in vitro. J Exp Med. 1978 Jun 1;147(6):1727–1743. doi: 10.1084/jem.147.6.1727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Thompson G. N. Failure of taurine to improve fat absorption in cystic fibrosis. J Inherit Metab Dis. 1988;11 (Suppl 2):158–160. doi: 10.1007/BF01804224. [DOI] [PubMed] [Google Scholar]
  44. Thompson G. N., Robb T. A., Davidson G. P. Taurine supplementation, fat absorption, and growth in cystic fibrosis. J Pediatr. 1987 Oct;111(4):501–506. doi: 10.1016/s0022-3476(87)80108-7. [DOI] [PubMed] [Google Scholar]
  45. Vercelli D., Jabara H. H., Cunningham-Rundles C., Abrams J. S., Lewis D. B., Meyer J., Schneider L. C., Leung D. Y., Geha R. S. Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest. 1990 May;85(5):1666–1671. doi: 10.1172/JCI114618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. WALKER R. B., WARIN R. P. The incidence of eczema in early childhood. Br J Dermatol. 1956 May;68(5):182–183. doi: 10.1111/j.1365-2133.1956.tb12805.x. [DOI] [PubMed] [Google Scholar]
  47. Weber A. M., Roy C. C., Morin C. L., Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med. 1973 Nov 8;289(19):1001–1005. doi: 10.1056/NEJM197311082891903. [DOI] [PubMed] [Google Scholar]
  48. Zentler-Munro P. L., Fitzpatrick W. J., Batten J. C., Northfield T. C. Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut. 1984 May;25(5):500–507. doi: 10.1136/gut.25.5.500. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES